NYSEAMERICAN:INFU InfuSystem (INFU) Stock Forecast, Price & News $9.64 -0.20 (-2.03%) (As of 09/29/2023 08:53 PM ET) Add Compare Share Share Today's Range$9.59▼$9.9350-Day Range N/A52-Week Range$6.10▼$11.44Volume32,000 shsAverage Volume61,611 shsMarket Capitalization$203.02 millionP/E Ratio321.44Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability InfuSystem MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.61% of Float Sold ShortDividend StrengthN/ASustainability-1.20Upright™ Environmental ScoreNews Sentiment0.84Based on 2 Articles This WeekInsider TradingSelling Shares$864,215 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.00 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for InfuSystem. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.61% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in InfuSystem has recently decreased by 15.16%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Previous Next 4.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInfuSystem has received a 55.56% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Medical dispensing pumps", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for InfuSystem is -1.20. Previous Next 2.7 News and Social Media Coverage News SentimentInfuSystem has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for InfuSystem this week, compared to 0 articles on an average week. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $864,215.00 in company stock.Percentage Held by Insiders18.50% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.03% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 321.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 119.71.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 321.44, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 136.71.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 4.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About InfuSystem (NYSEAMERICAN:INFU) StockInfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Read More INFU Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INFU Stock News HeadlinesSeptember 27, 2023 | americanbankingnews.comInfuSystem (NYSEAMERICAN:INFU) Share Price Passes Above 200 Day Moving Average of $0.00September 21, 2023 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Accuray (ARAY)October 2, 2023 | Legacy Research (Ad)Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”September 21, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Technology Companies: Societal CDMO (SCTL), AXT (AXTI) and comScore (SCOR)September 18, 2023 | finance.yahoo.comElastomeric Infusion Pumps Market to grow by USD 800.97 million from 2022-2027 | North America to account for 44% of market growth - TechnavioSeptember 11, 2023 | markets.businessinsider.comAnalysts Conflicted on These Technology Names: Bio-Techne (TECH) and Upstart Holdings (UPST)September 5, 2023 | finance.yahoo.comInfuSystem to Participate in Lake Street’s 7th Annual Best Ideas Growth (BIG7) Conference September 14, 2023August 16, 2023 | uk.finance.yahoo.comQ2 2023 Sanara Medtech Inc Earnings CallOctober 2, 2023 | Oxford Club (Ad)Better Than Oil StocksThe best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. August 3, 2023 | finance.yahoo.comInfuSystem Reports Second Quarter 2023 Financial ResultsJuly 31, 2023 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for InfuSystem Holdings, Inc. (INFU)July 27, 2023 | finance.yahoo.comInfuSystem to Report Second Quarter 2023 Financial Results on August 3, 2023July 26, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: CareDx (CDNA), Merit Medical Systems (MMSI) and HealthStream (HSTM)July 20, 2023 | finance.yahoo.comNegative Pressure Wound Therapy Systems Global Market is Projected to Boost at a CAGR of ~5% by 2028 | DelveInsightJuly 18, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Trulieve Cannabis (OtherTCNNF) and QuidelOrtho (QDEL)July 12, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Apyx Medical (APYX) and Leap Therapeutics (LPTX)July 6, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Guardant Health (GH) and iSpecimen (ISPC)June 29, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Societal CDMO (SCTL) and Evolv Technologies Holdings (EVLV)June 27, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and REPRO-MED Systems (KRMD)June 22, 2023 | msn.comInfuSystem: Long-Term Business Economics Eroding Value, Reiterate HoldJune 20, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Repligen (RGEN)May 5, 2023 | finance.yahoo.comInfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023May 4, 2023 | finance.yahoo.comInfuSystem Reports First Quarter 2023 Financial ResultsMay 3, 2023 | marketwatch.com2023-2030 Large Volume Infusion Pumps Market Size (Growth and Outlook) includes Main Business Overview | with [90 Pages]April 27, 2023 | finance.yahoo.comInfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023April 25, 2023 | finance.yahoo.comInfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy SystemsMarch 19, 2023 | finance.yahoo.comInfuSystem Holdings, Inc. (AMEX:INFU) Q4 2022 Earnings Call TranscriptSee More Headlines Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address INFU Company Calendar Last Earnings8/03/2023Today10/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:INFU Previous SymbolNYSE:INFU CUSIPN/A CIK1337013 Webir.infusystem.com Phone(124) 291-1210Fax800-455-4338Employees420Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio321.44 Forward P/E RatioN/A P/E GrowthN/ANet Income$20,000.00 Net Margins0.56% Pretax Margin0.93% Return on Equity1.36% Return on Assets0.66% Debt Debt-to-Equity Ratio0.72 Current Ratio2.22 Quick Ratio1.78 Sales & Book Value Annual Sales$109.91 million Price / Sales1.85 Cash Flow$0.65 per share Price / Cash Flow14.80 Book Value$2.32 per share Price / Book4.16Miscellaneous Outstanding Shares21,060,000Free Float17,160,000Market Cap$203.02 million OptionableNot Optionable Beta1.25 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Richard A. DiIorio (Age 48)CEO & Director Comp: $806.26kMs. Carrie A. Lachance B.S.N. (Age 46)M.B.A., R.N., Pres, COO & Director Comp: $473.54kMr. Barry G. Steele (Age 52)Exec. VP & CFO Mr. Addam Chupa (Age 44)Exec. VP & Chief Information Officer Jeanie LatzCorp. Sec.Key CompetitorsProfound MedicalNASDAQ:PROFQuipt Home MedicalNASDAQ:QIPTNeuroPaceNASDAQ:NPCETELA BioNASDAQ:TELALyra TherapeuticsNASDAQ:LYRAView All CompetitorsInsiders & InstitutionsBarclays PLCBought 3,653 shares on 9/21/2023Ownership: 0.017%R. Rimmy MalhotraSold 5,000 sharesTotal: $50,950.00 ($10.19/share)R. Rimmy MalhotraSold 12,500 sharesTotal: $128,000.00 ($10.24/share)R. Rimmy MalhotraSold 5,000 sharesTotal: $50,850.00 ($10.17/share)R. Rimmy MalhotraSold 5,000 sharesTotal: $51,550.00 ($10.31/share)View All Insider TransactionsView All Institutional Transactions INFU Stock - Frequently Asked Questions How have INFU shares performed in 2023? InfuSystem's stock was trading at $9.30 at the start of the year. Since then, INFU shares have increased by 3.7% and is now trading at $9.64. View the best growth stocks for 2023 here. Are investors shorting InfuSystem? InfuSystem saw a decline in short interest in September. As of September 15th, there was short interest totaling 296,600 shares, a decline of 15.2% from the August 31st total of 349,600 shares. Based on an average daily volume of 50,800 shares, the days-to-cover ratio is currently 5.8 days. Currently, 1.6% of the shares of the stock are short sold. View InfuSystem's Short Interest. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) issued its earnings results on Thursday, August, 3rd. The medical instruments supplier reported $0.02 EPS for the quarter. The medical instruments supplier had revenue of $31.74 million for the quarter. InfuSystem had a trailing twelve-month return on equity of 1.36% and a net margin of 0.56%. What guidance has InfuSystem issued on next quarter's earnings? InfuSystem updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $120.91M-, compared to the consensus revenue estimate of $120.00 million. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS). What is InfuSystem's stock symbol? InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU." How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is InfuSystem's stock price today? One share of INFU stock can currently be purchased for approximately $9.64. How much money does InfuSystem make? InfuSystem (NYSEAMERICAN:INFU) has a market capitalization of $203.02 million and generates $109.91 million in revenue each year. The medical instruments supplier earns $20,000.00 in net income (profit) each year or $0.03 on an earnings per share basis. How many employees does InfuSystem have? The company employs 420 workers across the globe. How can I contact InfuSystem? InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The official website for the company is ir.infusystem.com. The medical instruments supplier can be reached via phone at (124) 291-1210 or via fax at 800-455-4338. This page (NYSEAMERICAN:INFU) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.